Batchelor Children's Research Institute - University of Miami — Miami, Florida

Batchelor Children's Research Institute - University of Miami is a clinical research site located in Miami, Florida, United States 33136.

Crixeo Clinical Trials Trust Score: 91/100 (GOOD). This profile has not yet been claimed by the site owner.

Batchelor Children's Research Institute - University of Miami has participated in 2 clinical trials.

Therapeutic areas: Cystic Fibrosis, Sickle Cell Disease.

Sponsors: Syntara, Micelle BioPharma Inc.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Miami

Browse all research sites in Florida · View every site in Miami

Sponsor Feasibility Report

Trust Score: 91/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Batchelor Children's Research Institute - University of Miami?

Batchelor Children's Research Institute - University of Miami has a Crixeo Trust Score of 91/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Batchelor Children's Research Institute - University of Miami conducted?

Batchelor Children's Research Institute - University of Miami has 2 clinical trials on record. Their work covers Cystic Fibrosis, Sickle Cell Disease.

Is Batchelor Children's Research Institute - University of Miami accredited by Crixeo Clinical Trials?

Batchelor Children's Research Institute - University of Miami has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Batchelor Children's Research Institute - University of Miami?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.